The retinal drugs market is experiencing significant growth due to the increasing prevalence of age-related macular degeneration (AMD) and diabetic retinopathy worldwide. With advancements in medical research, innovative macular degeneration treatments are being developed, driving market expansion. Pharmaceutical companies are focusing on the development of ophthalmic pharmacotherapy targeting...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian